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Case Report
Successful Treatment of Bronchoesophageal Fistula
With Esophageal and Bronchial Stenting
Cheng-Yi Wang,2,5 Chien-Hong Chou,2,6 Hsiu-Po Wang,3 Jin-Shing Chen,4 Peilin Lee1,2*
Bronchoesophageal fistula is reported in 5–10% of patients with esophageal cancer. In most of these cases,
the insertion of a single stent, either a tracheobronchial or an esophageal stent, is sufficient to seal off 
the fistula. In this case we describe a 67-year-old man with esophageal cancer and complications of
bronchoesophageal fistula, which resulted in repeated pneumonia and acute respiratory failure. Initially,
two expandable metallic membranous esophageal stents were placed to cover the fistula. However, the
esophageal stent failed to stop the air leak and dislodged into the stomach. Thereafter, a bronchial stent
was placed at the right intermediate bronchus and successfully stopped the air leak. The patient was then
weaned from the ventilator 1 week after the insertion of a bronchial stent. In conclusion, stenting in both
the esophagus and airways should be considered when both are severely invaded by malignancy, when the
airway is compressed, or when the fistula is insufficiently sealed by an esophageal stent.
Key Words: bronchoesophageal fistula, respiratory failure, stent
Bronchoesophageal (BE) fistula can be palliated
by stent insertion. In most cases, a single stent,
either a tracheobronchial or an esophageal stent,
is sufficient to overcome the fistula. However, in
some cases, double stents are needed to seal off
the BE fistula. In this case we describe a man with
esophageal cancer-related BE fistula, which resulted
in repeated pneumonia and acute respiratory fail-
ure. The BE fistula was successfully treated with
two esophageal stents and one bronchial stent,
which helped to wean the patient from mechanical
ventilation.
Case Report
A 67-year-old man had odynophagia, cough, and
body weight loss for 6 months. Medical history
showed a perforated peptic ulcer treated with
truncal vagotomy and pyloroplasty 13 years ago,
and medically-controlled hypertension and dia-
betes mellitus. Panendoscopy (PES) on June 3,
2005 showed an ulcerated esophageal tumor
32−40 cm below the incisors. Biopsy was per-
formed and the pathologic report was squamous
cell carcinoma. Therefore, the patient underwent
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concurrent chemo-radiotherapy from June 30 to
July 11, 2005.
On July 21, 2005, the patient had right lower
lobe (RLL) pneumonia that partially responded
to antibiotic treatments. Bronchoscopy disclosed
esophageal cancer invading the right intermediate
bronchus without BE fistula. However, sudden
massive hematemesis with respiratory failure oc-
curred on August 3, 2005. Emergent endotracheal
intubation was performed and mechanical venti-
lation support was given.
A milk-like substance was aspirated from the
endotracheal tube after enteric feeding on August
10, 2005. In addition, persistent air bubbles were
drained from the nasogastric tube (NGT) and the
ventilator showed a persistent air leak with 150cc
tidal volume per breath. Follow-up chest radiog-
raphy showed progression of the RLL pneumo-
nia. The patient also needed a higher fraction 
of inspired oxygen. BE fistula was suspected and 
a left-sided double-lumen endotracheal tube was
inserted to maintain better oxygen saturation.
PES was performed on August 15, 2005 and
showed a circumferential ulcerative lesion with lu-
minal stenosis in the lower esophagus at 30–40 cm
below the incisor. An expandable metallic mem-
branous esophageal stent (Microvasive, Boston
Scientific Corp., Boston, MA, USA) was placed at
28–40 cm below the incisors. There was a fistula
over the upper-end of the esophageal stent, which
was not covered by the stent membrane. Therefore,
another stent (Microvasive) was placed at 24–
34 cm below the incisors to bypass the defect
(Figure 1). The air leak did not improve after the
insertion of the esophageal stents and chest radi-
ography showed that the second stent dislodged
into the stomach in the morning of August 16,
2005 (Figure 2). Emergency PES on August 16,
2005 also confirmed this observation. The second
stent was extracted with a snare 22–23 cm from the
incisors and was overlapped with the first stent at
32–33 cm from the incisor. However, the air leak
persisted after revision on August 17, 2005. Bron-
choscope was repeated and it revealed a fistula
opening into the right intermediate bronchus
around the orifice of the common basal bronchus.
Therefore, on August 19, 2005, an expandable cov-
ered metallic 4-cm-long × 18-mm-diameter stent
(Ultraflex, Boston Scientific Corp, Boston, MA,
USA) was placed at the right intermediate bronchus
near the orifice of the common basal bronchus to
cover the defect. Thereafter, no air leak was detected
(Figure 3). The RLL pneumonia was better con-
trolled after the BE fistula was successfully by-
passed with the bronchial stent. The patient was
weaned from the ventilator on August 26, 2005.
Discussion
BE fistula is a devastating complication reported
in 5−10% of patients with esophageal cancer.1
Figure 1. Endoscopy-guided insertion of two covered 
expandable metallic esophageal stents to bypass the
esophageal mucosal defect (arrow).
Figure 2. The esophageal stent (arrow) migrated to the
stomach 1 day after insertion.
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Treatment should be prompt,2 with the goal of
sealing off the fistula. In Burt’s study, the two
most commonly associated primary tumors are
esophageal (77%) and lung cancer (16%),3 and
it is more likely to arise in locally advanced 
cancer.4
Diagnosis is difficult without the typical signs
and symptoms. Recurrent cough is the most com-
mon symptom (56−65%), especially for those on
a liquid diet.5,6 Aspiration (37%) and fever (25%)
are next, often due to pneumonia.6 Barium esoph-
agogram is usually the diagnostic study of choice.3
Esophagoscopy and bronchoscopy are also able
to demonstrate the fistula.3
Most patients succumb to respiratory failure
within 6 weeks of diagnosis if the fistula is not
sealed.3 In 1990, Song et al7 reported their suc-
cess with silicone-covered expandable esophageal
stents, which lowered the rate of complications and
mortality compared to conventional treatment.
Stenting has since become the management of
choice.
In most cases, insertion of a single stent, ei-
ther a tracheobronchial or an esophageal stent, is
sufficient to seal off the fistula. A second stent is
indicated if dyspnea or dysphagia is not relieved.
Stenting in both the esophagus and airways should
be considered when both are severely invaded by
malignancy, when there is airway compression,
or when the fistula is insufficiently sealed by an
esophageal stent.8
Covered stents have a higher risk of displace-
ment than uncovered ones, despite the higher 
effectiveness.9,10 After bronchial stent insertion,
our patient rapidly recovered from both the pneu-
monia and air leak, and was weaned from venti-
lation. This supports other findings that the early
recognition and management of BE fistula with
BE stent improves outcome.
In conclusion, we demonstrated that an eso-
phageal cancer-related BE fistula was successfully
treated with an esophageal and a bronchial stent.
This procedure should be considered if a single
stent, either an esophageal stent or a bronchial
stent, fails to overcome the complications caused
by BE fistula. Awareness of the possibility of BE fis-
tula, prompt diagnosis, and immediate treatment
are key factors in saving the lives of such patients.
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Figure 3. Fluoroscopy showed the properly positioned
esophageal stents (arrowheads) and right-intermediate
bronchial stent (arrow).
